Results 11 to 20 of about 67,152 (253)
Frontiers in Pharmacology, 2023 Objectives: Our objective was to analyse effectiveness and safety of oral anticoagulants (OAC) for stroke prevention in non-valvular atrial fibrillation.Material and methods: Population-based cohort study including adults initiating oral anticoagulants ...
Maria Giner-Soriano +18 more
doaj +1 more source
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
Рациональная фармакотерапия в кардиологии, 2021 Atrial fibrillation and renal dysfunction often coexist, each disorder may predispose to the other and contribute to worsening prognosis. Both atrial fibrillation and chronic kidney disease are associated with increased risk of stroke and thromboembolic ...
Z. D. Kobalava +2 more
doaj +1 more source
Direct oral anticoagulants for electrical cardioversion
Кардиоваскулярная терапия и профилактика, 2021 The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using
A. N. Volovchenko +2 more
doaj +1 more source
Direct oral anticoagulants (DOACs) [PDF]
Vascular Medicine, 2015 DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects ...
Matthew T. Rondina, Sara R. Vazquez
openaire +3 more sources
Clinical Case Reports, 2022 Venous thromboembolism is often treated with direct oral anticoagulants. In order for direct oral anticoagulants to be effective, patients must adhere to a specific dosing strategy.
Trisha E Jethwa +2 more
doaj +1 more source
Use of New Oral Anticoagulants/ Direct Oral Anticoagulants in Malignant Patients [PDF]
Cureus, 2020 Vitamin K antagonists are being used in the last five decades as an effective anticoagulant. However, for the past few years, new oral anticoagulants (NOACs) have been introduced as newer anticoagulant agents, which are gradually replacing the previously used vitamin K antagonist.
Syed Owais Zaidi +4 more
openaire +3 more sources
How we treat bleeding associated with direct oral anticoagulants [PDF]
, 2016 Direct oral anticoagulants are at least as effective as vitamin K antagonists for the prevention and treatment of thromboembolism. Unfortunately, differently from vitamin K antagonists, they have the great drawback of lacking specific antidotes in the ...
Franchini, Massimo +4 more
core +1 more source
Direct oral anticoagulants: first airbag
Медицинский совет, 2019 The safety profile of oral anticoagulants (DOACs) was confirmed in the large-scale studies, the increased risk of hemorrhagic events does still exist, which may be caused by the nature of the patient’s concomitant pathology, the resulting injury or the ...
A. N. Sokolova, A. I. Skripka
doaj +1 more source
JACC: Cardiovascular Interventions, 2014 This chapter reviews the new direct oral anticoagulants—thrombin inhibitor and Xa inhibitors. The specific drugs are reviewed as well as the specific indications—prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and then acute coronary syndrome.
Jerrold H. Levy +3 more
openaire +4 more sources
Tutorial in oral antithrombotic therapy: Biology and dental implications [PDF]
, 2013 Objectives: Recent developments of new direct oral anticoagulants that target specific clotting factors necessitate understanding of coagulation biology.
Baird, Alison E. +5 more
core +1 more source